Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4065 USD | +6.44% | -5.24% | -29.30% |
May. 09 | Transcript : Virios Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Virios Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gregory Duncan
CEO | Chief Executive Officer | 59 | 17-12-31 |
Angela Walsh
DFI | Director of Finance/CFO | 58 | 20-03-31 |
Ralph Grosswald
COO | Chief Operating Officer | 55 | 20-03-31 |
R. Gendreau
CTO | Chief Tech/Sci/R&D Officer | 68 | 12-02-27 |
Richard Burch
BRD | Director/Board Member | 67 | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Thomas
BRD | Director/Board Member | 70 | 20-12-20 |
Richard Whitley
BRD | Director/Board Member | 78 | 20-12-20 |
Gregory Duncan
CEO | Chief Executive Officer | 59 | 17-12-31 |
Abel de la Rosa
BRD | Director/Board Member | 61 | 20-12-20 |
William Pridgen
FOU | Founder | 63 | 12-02-27 |
Richard Burch
BRD | Director/Board Member | 67 | 13-12-31 |
David Keefer
BRD | Director/Board Member | 71 | 17-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,257,937 | 17,387,608 ( 90.29 %) | 0 | 90.29 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.30% | 7.83M | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- VIRI Stock
- Company Virios Therapeutics, Inc.